DMPK and neuroblastoma: Indeed, STIRUR 41 is capable of inhibiting NB vascular mimicry and these findings are in line with our recent study demonstrating that GeGe3, another pyrazolyl-urea derivative [39, 40], with a similar structure to STIRUR41 (Figure 9), markedly inhibited physiological and tumor angiogenesis, in vitro and in vivo, by directly targeting MAPK and PI3K pathways and dystrophia myotonica protein kinase (DMPK)1 [39, 40].